文献速递血管炎其他结缔组织病

原发性血管炎患者的认知障碍及其他神经精神表现:一项系统综述

Cognitive impairment and other neuropsychiatric manifestations in patients with primary vasculitis: a systematic review.
PubMed 文献 · Semin Arthritis Rheum · 2025-08-05

该系统综述检索截至2023年12月31日的文献,纳入43项研究,涵盖1216例PCNSV、481例AAV、151例GCA、28例TAK、22例PAN、32例BD及54例其他类型血管炎患者。认知障碍在成人起病PCNSV中为275/750(11-62%),儿童起病PCNSV为126/433(10-54%),AAV为62/157(12-61%),GCA为4/12(20-43%),其他血管炎为261/486(20-67%)。结论指出认知障碍及其他神经精神表现在血管炎中常见,强调需常规进行神经心理学评估。

要点

  • 认知障碍在成人起病PCNSV中为275/750(11-62%),儿童起病PCNSV为126/433(10-54%)。
  • 认知障碍在AAV中为62/157(12-61%),GCA为4/12(20-43%),其他血管炎为261/486(20-67%)。
  • 仅12/43(28%)研究进行了标准化神经心理学测试,少数研究探讨相关因素或治疗反应。

核心结论

  • 认知障碍及其他神经精神表现在血管炎中常见,强调需常规进行神经心理学评估。

研究设计与样本

  • 系统综述检索Embase、PubMed、Scopus和PsycINFO截至2023年12月31日,纳入43项报告原发性血管炎认知障碍的研究,排除病例报告、综述及少于5例的病例系列,采用纽卡斯尔-渥太华量表评估研究质量。

主要发现

  • 成人起病PCNSV认知障碍为275/750(11-62%),儿童起病PCNSV为126/433(10-54%),AAV为62/157(12-61%),GCA为4/12(20-43%),其他血管炎为261/486(20-67%)。
  • 仅12/43(28%)研究进行了标准化神经心理学测试,少数研究探讨神经精神表现相关因素或治疗反应。
  • 这些研究报告与MRI异常相关,并与更差预后和/或更高疾病活动度相关。
  • 多数患者报告经免疫抑制治疗后改善,但残留神经精神症状。

局限性

  • 大多数研究为单中心回顾性研究,质量好或一般。
  • 仅12/43(28%)研究进行了标准化神经心理学测试。
  • 少数研究探讨了神经精神表现相关因素或治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vasculitis is an autoimmune disorder causing blood vessel inflammation, potentially affecting the central nervous system. This review explores neuropsychiatric manifestations with a focus on cognitive impairment in patients with vasculitis. METHODS: Embase, PubMed, Scopus, and PsycINFO were searched up to December 31st, 2023, for studies of primary vasculitis reporting on cognitive impairment. Case reports, reviews, and case series with <5 patients were excluded. Study quality was evaluated using the Newcastle Ottawa Scale. RESULTS: From the 4,249 identified studies, 43 met the inclusion criteria, comprising 1,216 cases of PCNSV, 481 of ANCA-associated vasculitis (AAV), 151 of giant cell arteritis (GCA), 28 of Takayasu arteritis (TAK), 22 of polyarteritis nodosa (PAN), 32 of Behçet's disease (BD), and 54 of other vasculitis types. Patients' ages ranged from 7.1-75.6 years and 11-100 % were female. Most studies were single-center retrospective studies of good or fair quality. Cognitive impairment was noted in 275/750 (11-62 %) of adult-onset PCNSV, 126/433 (10-54 %) of childhood-onset PCNSV, 62/157 (12-61 %) of AAV, 4/12 (20-43 %) of GCA, and 261/486 (20-67 %) of other vasculitis cases. Standardized neuropsychological testing was done in 12/43 (28 %) of studies. A minority of studies investigated factors associated with neuropsychiatric manifestations or response to treatment. These studies reported associations with MRI abnormalities and with worse prognosis and/or higher disease activity. Most patients were reported to improve after immunosuppressive therapy but have residual neuropsychiatric symptoms. CONCLUSIONS: Cognitive impairment and other neuropsychiatric manifestations are commonly reported in vasculitis, highlighting the need for routine neuropsychological assessments.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Chen RY, Mandzia J, Barra L, et al. Cognitive impairment and other neuropsychiatric manifestations in patients with primary vasculitis: a systematic review. Semin Arthritis Rheum. 2025. PMID: 40784139. doi:10.1016/j.semarthrit.2025.152806

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。